blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3356372

EP3356372 - NOVEL PROCESS FOR PREPARING THIENOPYRIMIDINE COMPOUND AND INTERMEDIATES USED THEREIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.06.2021
Database last updated on 31.05.2024
FormerThe patent has been granted
Status updated on  03.07.2020
FormerGrant of patent is intended
Status updated on  30.06.2020
FormerRequest for examination was made
Status updated on  16.05.2020
FormerGrant of patent is intended
Status updated on  21.01.2020
FormerRequest for examination was made
Status updated on  06.07.2018
FormerThe international publication has been made
Status updated on  05.05.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Hanmi Pharm. Co., Ltd.
214
Muha-ro
Paltan-myeon
Hwaseong-si, Gyeonggi-do 18536 / KR
[2018/32]
Inventor(s)01 / JANG, Wook
550
Dongtangiheung-ro
Hwaseong-si Gyeonggi-do 18469 / KR
02 / MOON, Young Ho
550
Dongtangiheung-ro
Hwaseong-si Gyeonggi-do 18469 / KR
03 / HA, Tae Hee
550
Dongtangiheung-ro
Hwaseong-si Gyeonggi-do 18469 / KR
04 / SUH, Kwee Hyun
550
Dongtangiheung-ro
Hwaseong-si Gyeonggi-do 18469 / KR
 [2018/32]
Representative(s)Brevalex
56, Boulevard de l'Embouchure
B.P. 27519
31075 Toulouse Cedex 2 / FR
[2018/32]
Application number, filing date16860330.631.10.2016
[2018/32]
WO2016KR12335
Priority number, dateKR2015015199330.10.2015         Original published format: KR 20150151993
[2018/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017074147
Date:04.05.2017
Language:EN
[2017/18]
Type: A1 Application with search report 
No.:EP3356372
Date:08.08.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 04.05.2017 takes the place of the publication of the European patent application.
[2018/32]
Type: B1 Patent specification 
No.:EP3356372
Date:05.08.2020
Language:EN
[2020/32]
Search report(s)International search report - published on:KR04.05.2017
(Supplementary) European search report - dispatched on:EP25.02.2019
ClassificationIPC:C07D495/04
[2019/13]
CPC:
C07D495/04 (EP,US); A61K31/497 (US); A61K31/519 (US);
A61P35/00 (EP,US)
Former IPC [2018/32]C07D495/04, C07D403/10, C07D403/12, A61K31/519, A61K31/497
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/32]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NEUARTIGES VERFAHREN ZUR HERSTELLUNG EINER THIENOPYRIMIDINVERBINDUNG UND DARIN VERWENDETE ZWISCHENPRODUKTE[2018/32]
English:NOVEL PROCESS FOR PREPARING THIENOPYRIMIDINE COMPOUND AND INTERMEDIATES USED THEREIN[2018/32]
French:NOUVEAU PROCÉDÉ DE PRÉPARATION D'UN COMPOSÉ THIÉNOPYRIMIDINE ET INTERMÉDIAIRE UTILISÉ À CET ÉGARD[2018/32]
Entry into regional phase25.04.2018National basic fee paid 
25.04.2018Search fee paid 
25.04.2018Designation fee(s) paid 
25.04.2018Examination fee paid 
Examination procedure25.04.2018Amendment by applicant (claims and/or description)
25.04.2018Examination requested  [2018/32]
25.04.2018Date on which the examining division has become responsible
22.01.2020Communication of intention to grant the patent
13.05.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
13.05.2020Fee for grant paid
13.05.2020Fee for publishing/printing paid
30.06.2020Information about intention to grant a patent
30.06.2020Receipt of the translation of the claim(s)
Opposition(s)07.05.2021No opposition filed within time limit [2021/28]
Fees paidRenewal fee
19.10.2018Renewal fee patent year 03
25.10.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.10.2016
AL05.08.2020
AT05.08.2020
CY05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
IT05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
MK05.08.2020
MT05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
SM05.08.2020
TR05.08.2020
BE31.10.2020
CH31.10.2020
FR31.10.2020
IE31.10.2020
LI31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
[2022/32]
Former [2022/27]HU31.10.2016
AL05.08.2020
AT05.08.2020
CY05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
IT05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
MT05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
SM05.08.2020
TR05.08.2020
BE31.10.2020
CH31.10.2020
FR31.10.2020
IE31.10.2020
LI31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/46]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
IT05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
SM05.08.2020
BE31.10.2020
CH31.10.2020
FR31.10.2020
IE31.10.2020
LI31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/37]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
IT05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
SM05.08.2020
BE31.10.2020
CH31.10.2020
FR31.10.2020
LI31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/36]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
IT05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SI05.08.2020
SK05.08.2020
SM05.08.2020
BE31.10.2020
FR31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/35]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
IT05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SK05.08.2020
SM05.08.2020
FR31.10.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/34]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
IT05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SK05.08.2020
SM05.08.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/31]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
MC05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SK05.08.2020
SM05.08.2020
LU31.10.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/28]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SK05.08.2020
SM05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/25]AL05.08.2020
AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SM05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/22]AT05.08.2020
CZ05.08.2020
DK05.08.2020
EE05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
RO05.08.2020
RS05.08.2020
SE05.08.2020
SM05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/21]AT05.08.2020
DK05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
RS05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/12]AT05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
NL05.08.2020
PL05.08.2020
RS05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/10]AT05.08.2020
ES05.08.2020
FI05.08.2020
HR05.08.2020
LT05.08.2020
LV05.08.2020
PL05.08.2020
RS05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
IS05.12.2020
PT07.12.2020
Former [2021/09]AT05.08.2020
ES05.08.2020
FI05.08.2020
LT05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
GR06.11.2020
PT07.12.2020
Former [2021/08]ES05.08.2020
FI05.08.2020
LT05.08.2020
SE05.08.2020
BG05.11.2020
NO05.11.2020
PT07.12.2020
Former [2021/07]FI05.08.2020
LT05.08.2020
NO05.11.2020
Documents cited:Search[AP]WO2016108623  (HANMI PHARM IND CO LTD [KR]) [AP] 1-15* the whole document *;
 [E]WO2017092523  (SHENZHEN TARGETRX INC [CN]) [E] 1-15 * page 15 - page 16 *
International search[A]US6245759  (BILODEAU MARK T [US], et al) [A] 1-17 * See abstract; claims 1-3. *;
 [A]WO2011162515  (HANMI HOLDINGS CO LTD [KR], et al) [A] 1-17 * See abstract; claim 1 ; page 27, line 19-page 29, line 27; page 27, Reaction Scheme (I). *;
 [A]US2012065233  (GREGOR VLAD EDWARD [US], et al) [A] 1-17* See abstract; claims 1-34; paragraphs [0255]-[0320]. *;
 [A]KR20140118575  (HANMI PHARM IND CO LTD [KR]) [A] 1-17 * See abstract; claim 1; paragraphs [0096]-[0125]. *;
 [A]  - PHOUJDAR, M. S. et al., "Microwave-based synthesis of novel thienopyrimidine bioisosteres of gefitinib", Tetrahedron Letters, (20080000), vol. 49, pages 1269 - 1273, XP022423221 [A] 1-17 * See page 1269, left column, lines 1-12; page 1271, Scheme 1. *

DOI:   http://dx.doi.org/10.1016/j.tetlet.2007.11.135
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.